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Pseudomonas stutzeri is a Gram-negative, rod-shaped, motile, single polar-ﬂagellated,
soil bacterium that was ﬁrst isolated from human spinal ﬂuid and is widely distributed
in the environment. It was isolated as an uncommon opportunistic pathogen from
humans, and a few cases of P. stutzeri-induced peritonitis have been reported in
patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Catheter
removal with antibiotic treatment is generally recommended because peritonitis by
Pseudomonas species is commonly associated with catheter-related infection. Here,
we describe the ﬁrst case of P. stutzeri-induced peritonitis in an 82-year-old woman
in Korea. She had received two antipseudomonal antibiotics, an aminoglycoside
(isepamicin, Yuhan corporation, Seoul, Korea) and a ﬂuoroquinolone (ciproﬂoxacin),
and was successfully treated without removal of the CAPD catheter.
& 2013. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The incidence of peritonitis in patients undergoing continuous
ambulatory peritoneal dialysis (CAPD) has signiﬁcantly decreased
recently compared to rates in the past because of the develop-
ment of peritoneal dialysis methods and catheter-related tech-
niques, continuous patient education, and the establishment of
antibiotic treatment guidelines; however, peritonitis remains an
important cause of peritoneal dialysis failure [1]. In peritonitis
induced by a single microorganism strain, coagulase-negative
staphylococcus was the most common cause of peritonitis
(24.3%), followed by Streptococcus, Staphylococcus, Escherichia
coli, and Pseudomonas aeruginosa. Peritonitis induced by multiple
microorganism strains has been reported in 7% of cases [2].n Society of Nephrology. Publi
c-nd/4.0/).
al Medicine, Nephrology
Hospital, 7-206, 3-ga,
rea.Pseudomonas stutzeri was ﬁrst isolated from human spinal
ﬂuid as a Gram-negative motile organism with a single polar
ﬂagella. P. stutzeri is widely distributed in the environment and
rarely causes infections, but it has been isolated as an oppor-
tunistic pathogen in clinical conditions [3].
P. stutzeri-induced peritonitis in patients with CAPD was
reported by Ceri et al. [4] overseas, but no cases have so far
been reported in Korea. With regard to inﬂammatory diseases
other than peritonitis, only one case of choroid plexitis has
been reported domestically [5]. In this report, we present a
case of peritonitis by an uncommon pathogen, P. stutzeri, in a
patient undergoing CAPD treated without catheter removal.Case report
An 82-year-old womanwho had undergone CAPD for 1 year
for the treatment of end-stage renal disease secondary to
hypertension was hospitalized for a cloudy peritoneal dialysisshed by Elsevier. This is an open access article under the CC BY-NC-ND
Kidney Res Clin Pract 32 (2013) 81–8382efﬂuent for 1 day before admission. She had a history of
cholecystectomy due to gallstones at 72 years of age.
Physical examination on admission revealed abdominal
distension, decreased bowel sounds, and mild diffuse abdom-
inal tenderness. The peritoneal catheter site displayed no
erythema or discharge. The patient’s vital signs were as
follows: body temperature, 36.8 1C; blood pressure, 185/
88 mmHg; and heart rate, 78/min in sinus rhythm.
Laboratory analysis revealed the following: white blood cell
count of 10.4103/mm3 with 89% polymorphonucleocytes;
hemoglobin, 11.1 g/dL; platelet count, 304103/mm3; erythro-
cyte sedimentation rate, 64 mm/h; C-reactive protein level,
2.92 mg/dL. The patient’s blood chemistries were normal
except for a creatinine level of 6.33 mg/dL, blood urea nitrogen
level of 56.7 mg/dL, and albumin level of 2.8 g/dL. Chest
radiography showed mild pulmonary congestion with cardio-
megaly, whereas abdominal radiography revealed a mild
paralytic ileus (Fig. 1). Peritoneal ﬂuid analysis revealed a
leukocyte count of 9.92103/mm3 (polymorphonuclear leu-
kocytes, 84%; lymphocytes, 4%).
Empirical therapy was initiated with intraperitoneal cefa-
zolin (Dong-A pharmaceutical company limited, Seoul, Korea)
and isepamicin. Because P.stutzeri grew in the culture of the
peritoneal efﬂuent performed on admission, cefazolin was
discontinued from the 9th day of peritonitis, and ciproﬂoxacin
was administered orally in addition to the initial treatment.
The total treatment period was 3 weeks. The white blood cell
count of the peritoneal ﬂuid decreased from 9,920/mm3 on
admission to 6/mm3 on the 19th day of peritonitis, and the
dialysate efﬂuent that was cloudy on admission drained clearFigure 1. Abdominal radiograph. Paralytic ileus and the correct posi-
tion of a continuous ambulatory peritoneal dialysis(CAPD) catheter with
its tip with in the pelvis are shown.from the 3rd day of peritonitis. There were no other complica-
tions, and the patient is currently undergoing CAPD through
the outpatient nephrology service without recurrent peritonitis.Discussion
Identifying the causative microorganism is important for
antibiotic selection and the determination of a treatment
strategy in the management of CAPD peritonitis. Clinical
features and treatment methods vary according to the causa-
tive microorganism. Approximately 72% of CAPD peritonitis
cases can be treated with antibiotics, but the catheter must be
removed in the other 28% of cases because of recurrent and
intractable peritonitis such as fungal infections [6].
P. stutzeri is a widely distributed Gram-negative bacterium
that rarely causes infections. However, it has been isolated as
an opportunistic pathogen in immunocompromised hosts.
Cases of P. stutzeri have been reported in the form of osteo-
myelitis, arthritis, endocarditis, meningitis, pneumonia,
empyema, skin infections, eye infections, urinary tract infec-
tions, and diverticulitis, and susceptibility tests for several
antibiotics have been performed in epidemiological and case
reports.
Nearly all studies involving several antibiotics and bacterial
species have shown that P. stutzeri is sensitive to many more
antibiotics than P. aeruginosa, its most closely related species
and a well-known human pathogen [3]. The higher sensitivity
of P. stutzeri can be explained by its reduced exposure to
antibiotics because of its low incidence rate in clinical envir-
onments. Despite these results, when isolated in immunocom-
promised hosts, P. aeruginosa and other Pseudomonas spp.,
including P. stutzeri, did not show any signiﬁcant difference [7].
This ﬁnding implies that P. stutzeri has a range of antibiotic
resistance mechanisms, such as changes in outer membrane
proteins and lipopolysaccharide, and the presence of β-lactamase
has been described [8].
Siva et al. [9] reported that Pseudomonas is associated with
a higher catheter removal rate and conversion to hemodialysis
compared to general microorganisms, and immediate removal
of the peritoneal catheter and treatment with two types ofTable 1. Antibiotic susceptibility testing results from the patient’s
peritoneal ﬂuid
Antibiotics Sensitivities
Amikacin S (MIC ≤ 2)
Ampicillin/sulbactam S (MIC ¼ 4)
Aztreonam S (MIC ≤ 1)
Cefotaxime S (MIC ¼ 4)
Ceftazidime S (MIC ≤ 1)
Cefepime S (MIC ≤ 1)
Ciproﬂoxacin S (MIC ≤ 0.25)
Gentamicin S (MIC ≤ 1)
Imipenem S (MIC ≤ 1)
Piperacillin S (MIC ≤ 4)
Piperacillin/tazobactam S (MIC ≤ 4)
Tobramycin S (MIC ≤ 1)
Trimethomrim/sulfamethoxazole S (MIC ≤ 20)
Ticarcillin S (MIC ≤ 8)
Ticarcillin/clavulanate S (MIC ≤ 8)
Colistin S (MIC ≤ 0.5)
Levoﬂoxacin S (MIC ≤ 0.12)
Meropenem S (MIC ≤ 0.25)
Minocycline S (MIC ¼ 4)
MIC, minimum inhibitory concentration; S, sensitive.
Table 2. Peritoneal dialysis efﬂuent ﬁndings
Hospital day or day of peritonitis 1 3 6 14 19
Color Cloudy Clear Clear Clear Clear
Cell count (WBC)/mm3 9,920 720 8 9 6
Polymorphonuclear leukocytes (%) 84 34 — — —
WBC, white blood cell count.
Park et al / Pseudomonas stutzeri PD peritonitis 83antipseudomonal antibiotics decreased mortality through a
meta-analysis of 191 cases of peritonitis by Pseudomonas that
occurred in 2003–2006 in Australia. P. stutzeriwas identiﬁed in
15 (8%) of a total of 191 cases.
Ceri et al. [4] treated the patients with refractory CAPD
peritonitis due to P. stutzeri with susceptible antibiotics and
catheter removal. Tan et al. [10] described P. stutzeri as one of
the causative pathogens of recurrent peritonitis in pediatric
patients undergoing CAPD. However, no case has yet been
reported in Korea.
In this case, the patient was treated with antibiotics with-
out catheter removal because the isolated bacterium was
susceptible to ciproﬂocaxin and isepamicin (Table 1), there
was no evidence of an exit site infection or tunnel infection,
and her clinical symptoms improved after antibiotic adminis-
tration (Table 2).
According to the recommendations of the International
Society for Peritoneal Dialysis, catheter removal with antibiotic
treatment is recommended because peritonitis by Pseudomo-
nas species, which has the capacity to generate bioﬁlm, is
commonly associated with catheter-related infection [9,11].
In addition, like P. aeruginosa, P. stutzeri has a variety of
antibiotic resistance mechanisms. Thus, the administration
of two susceptible antibiotics with different mechanisms of
action is required [12].
In conclusion, management of P. stutzeri-induced peritonitis
should be the same as that with P. aeruginosa. However, careful
deliberation is necessary upon CAPD catheter removal because
P. stutzeri infection progresses according to host immunity and
antibiotic exposure as shown in this case.Conﬂict of interest
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